Periodontitis is a chronic inflammatory disease of the supporting structures of teeth, including the gingiva, periodontal ligament and alveolar bone. It is often silent yet causes a progressive destruction of the structures that hold the tooth in the bone. This results in periodontal pocket formation, gingival recession, tooth mobility, and eventual tooth loss. The condition affects approximately 50% of the population and typically progresses slowly, however, acute episodes may necessitate urgent treatment by a dentist.
GPs play an important role in the early identification and management of risk factors for periodontitis, such as age, smoking, diabetes, obesity, and obstructive sleep apnoea.
(image credit: https://upload.wikimedia.org/wikipedia/commons/0/01/Depiction_of_a_Periodontitis_patient.png)
A tooth consists of:
enamel (outermost)
dentin, which lies beneath the enamel and provides support
pulp, a soft tissue containing nerves and blood vessels
cementum, which covers the tooth root and helps anchor it to the surrounding bone
The periodontium, which supports and maintains the tooth in its socket, includes the gingiva (gums), periodontal ligament, alveolar bone, and cementum.
Dental plaque formation is a dynamic process:
adhesion of salivary proteins to the tooth surface
bacteria to attach and multiply to this coating, leading to the development of a structured biofilm
the periodontium responds with an inflammatory reaction
tissue destruction and compromise to the periodontal ligament occur
inflammation progresses from the gingival margin into the alveolar bone
periodontal pocket forms around a tooth, providing a reservoir of pathogenic bacteria and calculus (hardened, mineralised plaque)
halitosis
an unpleasant taste
gingival bleeding
drifting or loose teeth in advanced stages
pain is not commonly reported until the disease is severe
gingival inflammation and bleeding
formation of periodontal pockets, ie attachment loss (history of tooth mobility and spacing between teeth, teeth looking taller)
gingival recession and exposure of root surfaces
hormonal (puberty, pregnancy) or metabolic (obesity) changes causing localised or generalised inflammation of gums
smoking
poorly controlled diabetes
compromised immune response
insufficient routine oral hygiene
The disease burden increases with age and is linked to systemic health outcomes, including cardiovascular disease, and diabetes. Some studies have shown a bidirectional relationship between periodontitis and glycemic control, suggesting managing periodontitis positively influences control of blood sugar control in type 2 diabetes. Studies have also suggested deteriorating gums can be a sign of undiagnosed type 2 diabetes. Furthermore, there is growing evidence suggesting a link between obstructive sleep apnoea (OSA) and increased risk of periodontitis.
Current classification of periodontitis is based on:
stage: clinical and/or radiographic amount of tissue and bone loss as a result of periodontitis. Outlines the complexity of the treatment needed and indicates severity.
grade: reflects rate of progression, anticipated response to therapy, and risk factors e.g. smoking, diabetes
Periodontitis staging and grading is outlined in detail here. This system enables risk stratification and tailored care planning.
gingivitis (reversible inflammation without attachment loss)
necrotising periodontal disease (distinctive acute form, often with systemic symptoms)
endodontic–periodontal lesions (combined pulpal and periodontal origin)
desquamative gingivitis (often due to mucocutaneous diseases such as lichen planus)
rapid attachment loss and bone destruction, particularly in younger individuals
lack of correlation between plaque levels and disease severity
systemic signs such as fever or malaise (suggesting systemic disease or necrotising disease)
presentation in children (consider underlying systemic diseases such as leukaemia, type 1 diabetes, or cyclic neutropenia)
Children and adults with rapidly progressive disease require urgent collaborative care from periodontist and pediatric dentists.
The cornerstone of periodontitis management is the control of bacterial biofilm and modification of contributing risk factors. GPs should encourage patients to seek regular dental care and support behavioural changes.
Risk factor control: support for smoking cessation and diabetes optimisation
Oral hygiene instruction: brushing technique, flossing, and interdental cleaning should be reviewed and reinforced
recommend regular dentist visits for debridement, correction of plaque-retentive factors, and maintenance
Mouthwashes do not penetrate periodontal pockets but antiseptic mouthwashes may be a useful adjunct for short-term use in patients with gingivitis
short-term use of 1.5% topical hydrogen peroxide may be used for antiseptic properties
0.12% or 0.2% chlorhexidine mouthwash may be used no longer than two weeks for bactericidal, fungicidal and antiviral effects
periodontitis is severe (deep pockets, extensive attachment loss)
there is no response to primary care interventions
the disease is rapidly progressing or the patient is immunocompromised
Antibiotics are rarely indicated and should be reserved for specific scenarios with dentist or periodontist referral.
Therapeutic Guidelines. Periodontitis. 2019. (last accessed April 2025).
McColl, E. Periodontal tips for primary care. Br Dent J. 2022; 232: 72–73.
West N, Chapple I, et al. BSP implementation of European S3 - level evidence-based treatment guidelines for stage I-III periodontitis in UK clinical practice. Journal of Dentistry. 2021;106:103562.
Stöhr, J., Barbaresko, J., Neuenschwander, M. et al. Bidirectional association between periodontal disease and diabetes mellitus: a systematic review and meta-analysis of cohort studies. Sci Rep.2021;11: 13686.
Kalhan AC, Wong ML, Allen F, Gao X. Periodontal disease and systemic health: An update for medical practitioners. Annals. 2022;51(9):567-574.
After reading the clinical summary above and reviewing the references, complete the quiz to gain 30 minutes of EA CPD and 30 minutes of RP CPD.
You can either self-report CPD to your CPD home, or Medcast will track your learning via your personal CPD Tracker and you can download and report these points once a year. See our CPD Tracker FAQ.
Please log in or sign up for a free Medcast account to access the case study questions and achieve the CPD credits.
The Medcast medical education team is a group of highly experienced, practicing GPs, health professionals and medical writers.
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreCarpal tunnel syndrome (CTS) is one of the most common upper limb conditions. This FastTrack activity provides a concise summary of the diagnosis and management of CTS, including the use of the CTS-6 diagnostic tool and when to refer for surgical intervention. 30min each of RP and EA CPD available with the quiz.
New MBS items for GP chronic condition management plans (GPCCMPs) came into effect on July 1st 2025. This Business Skills FastTrack is designed to update GP practice owners and locums about the new GPCCMP item numbers, ensuring you maximise your billing practices without compromising on compliance. 30mins each RP and EA CPD available.
GPs play a critical role in identifying patients with a suspicion of lung cancer. This FastTrack fact sheet covers screening, diagnosis, and investigation of lung cancer in primary care, including updates on the new National Lung Cancer Screening program. Earn 30mins each of RP and EA CPD with the quiz.